July 1, 2026
Let’s not do that again
To say that the first half of 2026 has been difficult for diabetes device companies is like saying it gets hot in Arizona in the summer. Take a look at how the various companies have done so far this year in terms of stock performance.
MiniMed down 19.74%
Insulet down 44.57%
Tandem down 30.03%
Beta Bionics down 46.85%
Modular Medical down 59.02%
Abbott down 25.83%
Senseoincs UP 1.81%
Dexcom UP 3.41%
Not exactly what Momma Kliff . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
